Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis.
Hiroyuki KawaguchiMichiko MoriyamaHideki HashimotoPublished in: BMC health services research (2020)
A disease management program for diabetes patients organized by local public insurers in Japan reduced costs both by amending treatment processes and by subsequently improving the prognosis of the disease.
Keyphrases
- diabetic nephropathy
- healthcare
- end stage renal disease
- type diabetes
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiovascular disease
- mental health
- emergency department
- prognostic factors
- quality improvement
- insulin resistance
- glycemic control
- patient reported outcomes
- combination therapy
- replacement therapy